LOADING
Comparing Tesla Inc (TSLA) and Johnson & Johnson (JNJ) across the Consumer Discretionary and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | TSLA | JNJ |
|---|---|---|
| Price | $362.86 | $270.24 |
| Change Today | +5.14% | +1.07% |
| Market Cap | $1.43T | $651.3B |
| P/E Ratio | 324.0 | 31.4 |
| Forward P/E | 175.4 | 23.2 |
| PEG Ratio | 5.06 | 4.73 |
| EPS | $1.12 | $8.62 |
| Revenue Growth (YoY) | 25.5% | 6.6% |
| Profit Margin | 3.7% | 21.5% |
| Return on Equity | 4.7% | 25.7% |
| Dividend Yield | -- | 1.96% |
| Beta | 1.83 | 0.23 |
| 52-Week High | $498.83 | $276.47 |
| 52-Week Low | $297.38 | $170.33 |
| Volume | 59.2M | 6.2M |
Tesla Inc is the larger company by market capitalization. Johnson & Johnson trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Johnson & Johnson has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.